The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of QL1706 plus carboplatin/etoposide (EC) as first-line (1L) treatment for extensive-stage small-cell lung cancer (ES-SCLC): The results from a phase II single-arm study.
 
Yun Fan
No Relationships to Disclose
 
Zhehai Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Runxiang Yang
No Relationships to Disclose
 
Xuhong Min
No Relationships to Disclose
 
Huiwen Ma
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Hongmin Wang
No Relationships to Disclose
 
Huayuan Wang
No Relationships to Disclose
 
Lianghua Fang
No Relationships to Disclose
 
Xiaoyan Kang
No Relationships to Disclose